| GO ID | GO name | Interaction type | Reference |
|---|---|---|---|
| GO:0000737 | Dna catabolic process, endonucleolytic | Increases phenotype | PMID:39096083 |
| GO:0001541 | Ovarian follicle development | Affects phenotype | PMID:31071422 |
| GO:0001820 | Serotonin secretion | Increases phenotype | PMID:7664789; PMID:9022032; PMID:9022032 |
| GO:0002000 | Detection of renal blood flow | Affects phenotype | PMID:33476711 |
| GO:0002381 | Immunoglobulin production involved in immunoglobulin-mediated immune response | Increases phenotype | PMID:8102566 |
| GO:0002523 | Leukocyte migration involved in inflammatory response | Increases phenotype | PMID:39105374 |
| GO:0002639 | Positive regulation of immunoglobulin production | Increases phenotype | PMID:25237059 |
| GO:0002718 | Regulation of cytokine production involved in immune response | Increases phenotype | PMID:10886398 |
| GO:0002830 | Positive regulation of type 2 immune response | Affects phenotype | PMID:24089704; PMID:9931279 |
| GO:0003084 | Positive regulation of systemic arterial blood pressure | Increases phenotype | PMID:28987480 |
| GO:0003094 | Glomerular filtration | Affects phenotype | PMID:33476711 |
| GO:0003993 | Acid phosphatase activity | Increases phenotype | PMID:26215012 |
| GO:0004035 | Alkaline phosphatase activity | Affects phenotype | PMID:24485406; PMID:26215012 |
| GO:0004096 | Catalase activity | Affects phenotype | PMID:39096083 |
| GO:0004129 | Cytochrome-c oxidase activity | Decreases phenotype | PMID:31251452; PMID:33038468 |
| GO:0004197 | Cysteine-type endopeptidase activity | Affects phenotype | PMID:33497711 |
| GO:0004364 | Glutathione transferase activity | Affects phenotype | PMID:22416658; PMID:30359721; PMID:35066093 |
| GO:0004457 | Lactate dehydrogenase activity | Affects phenotype | PMID:22413763; PMID:24485406; PMID:27837179 |
| GO:0004602 | Glutathione peroxidase activity | Affects phenotype | PMID:17516994; PMID:20820944; PMID:23369933; PMID:33460233; PMID:39096083; PMID:22351102; PMID:23369933; PMID:23390552; PMID:24751971; PMID:24751971; PMID:24834726; PMID:24834726; PMID:25600690; PMID:25600690; PMID:33460233; PMID:39096083; PMID:39105374 |
| GO:0004784 | Superoxide dismutase activity | Decreases phenotype | PMID:17516994; PMID:17516994; PMID:22416658; PMID:24485406; PMID:24751971; PMID:20820944; PMID:23369933; PMID:25368988; PMID:32134168; PMID:33460233; PMID:39096083; PMID:22351102; PMID:22416658; PMID:24485406; PMID:23369933; PMID:23390552; PMID:24485406; PMID:24485406; PMID:24751971; PMID:24555655; PMID:24751971; PMID:25600690; PMID:26089086; PMID:32134168; PMID:33460233; PMID:39096083; PMID:39105374 |
| GO:0006089 | Lactate metabolic process | Affects phenotype | PMID:33038468 |
| GO:0006457 | Protein folding | Decreases phenotype | PMID:31251452 |
| GO:0006695 | Cholesterol biosynthetic process | Increases phenotype | PMID:24485406 |
| GO:0006749 | Glutathione metabolic process | Decreases phenotype | PMID:24970117; PMID:32134168; PMID:32134168; PMID:39096083; PMID:33497711; PMID:35066093; PMID:36646412; PMID:39096083; PMID:39105374 |
| GO:0006750 | Glutathione biosynthetic process | Affects phenotype | PMID:22416658; PMID:24485406; PMID:22416658; PMID:24485406; PMID:24751971; PMID:24039982; PMID:24485406; PMID:24485406; PMID:24751971; PMID:24751971; PMID:25600690; PMID:26215012; PMID:30359721 |
| GO:0006809 | Nitric oxide biosynthetic process | Increases phenotype | PMID:24751971; PMID:25600690; PMID:29981841 |
| GO:0006813 | Potassium ion transport | Affects phenotype | PMID:33038468 |
| GO:0006816 | Calcium ion transport | Increases phenotype | PMID:9405450 |
| GO:0006826 | Iron ion transport | Increases phenotype | PMID:9863766 |
| GO:0006833 | Water transport | Increases phenotype | PMID:19840149; PMID:20958918; PMID:22687538; PMID:7528928; PMID:9124401; PMID:9514918; PMID:9733774 |
| GO:0006915 | Apoptotic process | Increases phenotype | PMID:25953102; PMID:27714827; PMID:7867075; PMID:7867075; PMID:7867088 |
| GO:0006954 | Inflammatory response | Increases phenotype | PMID:31071422; PMID:37172713 |
| GO:0006955 | Immune response | Affects phenotype | PMID:3262595 |
| GO:0007006 | Mitochondrial membrane organization | Affects phenotype | PMID:33038468 |
| GO:0007154 | Cell communication | Decreases phenotype | PMID:12528335 |
| GO:0007224 | Smoothened signaling pathway | Decreases phenotype | PMID:31652400 |
| GO:0007566 | Embryo implantation | Affects phenotype | PMID:1238902 |
| GO:0008121 | Ubiquinol-cytochrome-c reductase activity | Decreases phenotype | PMID:33038468 |
| GO:0008137 | Nadh dehydrogenase (ubiquinone) activity | Decreases phenotype | PMID:33038468 |
| GO:0008177 | Succinate dehydrogenase (ubiquinone) activity | Decreases phenotype | PMID:31251452; PMID:33038468 |
| GO:0008203 | Cholesterol metabolic process | Affects phenotype | PMID:37172713 |
| GO:0008219 | Cell death | Increases phenotype | PMID:31404653; PMID:33497711; PMID:7867088 |
| GO:0008241 | Peptidyl-dipeptidase activity | Decreases phenotype | PMID:28987480 |
| GO:0008283 | Cell population proliferation | Decreases phenotype | PMID:25458486; PMID:25953102; PMID:27714827; PMID:27888128; PMID:29981841; PMID:8560497 |
| GO:0008284 | Positive regulation of cell population proliferation | Increases phenotype | PMID:10861847; PMID:25446860 |
| GO:0008361 | Regulation of cell size | Affects phenotype | PMID:30807803 |
| GO:0010466 | Negative regulation of peptidase activity | Affects phenotype | PMID:28987480 |
| GO:0010729 | Positive regulation of hydrogen peroxide biosynthetic process | Increases phenotype | PMID:8872981 |
| GO:0010918 | Positive regulation of mitochondrial membrane potential | Decreases phenotype | PMID:22910795 |
| GO:0010942 | Positive regulation of cell death | Increases phenotype | PMID:22910795; PMID:24816296; PMID:24973089; PMID:25849418; PMID:27720909 |
| GO:0015694 | Mercury ion transport | Increases phenotype | PMID:25145654; PMID:28536007 |
| GO:0016042 | Lipid catabolic process | Increases phenotype | PMID:17516994; PMID:17516994; PMID:22416658; PMID:24485406; PMID:24751971; PMID:24834726; PMID:20820944; PMID:23369933; PMID:25368988; PMID:21138989; PMID:22351102; PMID:26215012; PMID:22416658; PMID:24485406; PMID:22771764; PMID:23369933; PMID:23390552; PMID:24485406; PMID:24485406; PMID:24751971; PMID:24555655; PMID:24751971; PMID:24954677; PMID:25600690; PMID:25947387; PMID:26215012; PMID:32134168 |
| GO:0016049 | Cell growth | Affects phenotype | PMID:29981841 |
| GO:0018158 | Protein oxidation | Increases phenotype | PMID:22771764; PMID:22771764; PMID:23650045; PMID:23650045 |
| GO:0019432 | Triglyceride biosynthetic process | Increases phenotype | PMID:24485406; PMID:30807803 |
| GO:0019627 | Urea metabolic process | Affects phenotype | PMID:32599119 |
| GO:0019722 | Calcium-mediated signaling | Increases phenotype | PMID:9405450 |
| GO:0022602 | Ovulation cycle process | Affects phenotype | PMID:31071422 |
| GO:0022904 | Respiratory electron transport chain | Decreases phenotype | PMID:25926417 |
| GO:0030073 | Insulin secretion | Affects phenotype | PMID:23202902 |
| GO:0030168 | Platelet activation | Increases phenotype | PMID:30537864 |
| GO:0030336 | Negative regulation of cell migration | Increases phenotype | PMID:19539607 |
| GO:0030890 | Positive regulation of b cell proliferation | Affects phenotype | PMID:9693280 |
| GO:0031143 | Pseudopodium | Increases phenotype | PMID:30537864 |
| GO:0031966 | Mitochondrial membrane | Affects phenotype | PMID:33038468 |
| GO:0032633 | Interleukin-4 production | Increases phenotype | PMID:18432732 |
| GO:0032780 | Negative regulation of atp-dependent activity | Affects phenotype | PMID:9243794 |
| GO:0032930 | Positive regulation of superoxide anion generation | Increases phenotype | PMID:28987480 |
| GO:0033554 | Cellular response to stress | Affects phenotype | PMID:24036268 |
| GO:0033864 | Positive regulation of nad(p)h oxidase activity | Increases phenotype | PMID:25446860 |
| GO:0034440 | Lipid oxidation | Increases phenotype | PMID:106178; PMID:23650045; PMID:24970117; PMID:33460233; PMID:39096083; PMID:39105374 |
| GO:0035264 | Multicellular organism growth | Decreases phenotype | PMID:28536007 |
| GO:0035556 | Intracellular signal transduction | Increases phenotype | PMID:7698341 |
| GO:0035712 | T-helper 2 cell activation | Increases phenotype | PMID:8258322 |
| GO:0035812 | Renal sodium excretion | Decreases phenotype | PMID:16189294 |
| GO:0042092 | Type 2 immune response | Increases phenotype | PMID:7589090; PMID:7657819; PMID:7664789 |
| GO:0042102 | Positive regulation of t cell proliferation | Decreases phenotype | PMID:22910795 |
| GO:0042110 | T cell activation | Increases phenotype | PMID:8102566; PMID:9766631 |
| GO:0042113 | B cell activation | Increases phenotype | PMID:7867088; PMID:8102566; PMID:8766555; PMID:8898950 |
| GO:0042310 | Vasoconstriction | Increases phenotype | PMID:10790511; PMID:31415774; PMID:33476711 |
| GO:0042311 | Vasodilation | Increases phenotype | PMID:10790511; PMID:28987480 |
| GO:0042531 | Positive regulation of tyrosine phosphorylation of stat protein | Increases phenotype | PMID:22910795 |
| GO:0042554 | Superoxide anion generation | Increases phenotype | PMID:31071422; PMID:31415774 |
| GO:0042593 | Glucose homeostasis | Decreases phenotype | PMID:23202902 |
| GO:0043065 | Positive regulation of apoptotic process | Affects phenotype | PMID:21435368; PMID:22785175; PMID:22910795; PMID:23202902; PMID:27837179; PMID:32879258 |
| GO:0043410 | Positive regulation of mapk cascade | Increases phenotype | PMID:10861847 |
| GO:0044237 | Cellular metabolic process | Decreases phenotype | PMID:29298499; PMID:37172713 |
| GO:0045089 | Positive regulation of innate immune response | Increases phenotype | PMID:26456670 |
| GO:0045190 | Isotype switching | Increases phenotype | PMID:8102566 |
| GO:0045333 | Cellular respiration | Decreases phenotype | PMID:33038468 |
| GO:0045429 | Positive regulation of nitric oxide biosynthetic process | Decreases phenotype | PMID:23650045 |
| GO:0045907 | Positive regulation of vasoconstriction | Increases phenotype | PMID:28987480 |
| GO:0045931 | Positive regulation of mitotic cell cycle | Increases phenotype | PMID:22910795 |
| GO:0046034 | Atp metabolic process | Affects phenotype | PMID:33038468; PMID:33497711 |
| GO:0046330 | Positive regulation of jnk cascade | Increases phenotype | PMID:10861847 |
| GO:0046415 | Urate metabolic process | Decreases phenotype | PMID:32879258 |
| GO:0046449 | Creatinine metabolic process | Decreases phenotype | PMID:17516994; PMID:32599119; PMID:32879258 |
| GO:0046466 | Membrane lipid catabolic process | Increases phenotype | PMID:27837179; PMID:39414706 |
| GO:0046651 | Lymphocyte proliferation | Increases phenotype | PMID:9376071 |
| GO:0048246 | Macrophage chemotaxis | Increases phenotype | PMID:12834626 |
| GO:0048247 | Lymphocyte chemotaxis | Increases phenotype | PMID:12834626 |
| GO:0048874 | Host-mediated regulation of intestinal microbiota composition | Increases phenotype | PMID:31175882 |
| GO:0050729 | Positive regulation of inflammatory response | Increases phenotype | PMID:22822941; PMID:39414706 |
| GO:0050817 | Coagulation | Increases phenotype | PMID:35022635 |
| GO:0050861 | Positive regulation of b cell receptor signaling pathway | Decreases phenotype | PMID:28668464 |
| GO:0051881 | Regulation of mitochondrial membrane potential | Affects phenotype | PMID:33038468; PMID:37172713 |
| GO:0051882 | Mitochondrial depolarization | Increases phenotype | PMID:31404653; PMID:33497711 |
| GO:0051897 | Positive regulation of protein kinase b signaling | Increases phenotype | PMID:22910795 |
| GO:0055074 | Calcium ion homeostasis | Affects phenotype | PMID:29981841 |
| GO:0060073 | Micturition | Increases phenotype | PMID:33476711 |
| GO:0060208 | Proestrus | Affects phenotype | PMID:31071422 |
| GO:0061045 | Negative regulation of wound healing | Increases phenotype | PMID:19539607 |
| GO:0061098 | Positive regulation of protein tyrosine kinase activity | Increases phenotype | PMID:10092522; PMID:10092522; PMID:7698341; PMID:7698341 |
| GO:0061370 | Testosterone biosynthetic process | Affects phenotype | PMID:32134168; PMID:32134168; PMID:33460233; PMID:33460233 |
| GO:0070265 | Necrotic cell death | Increases phenotype | PMID:17516994; PMID:29045746 |
| GO:0070266 | Necroptotic process | Increases phenotype | PMID:21435368 |
| GO:0070374 | Positive regulation of erk1 and erk2 cascade | Affects phenotype | PMID:22910795; PMID:28668464 |
| GO:0070527 | Platelet aggregation | Increases phenotype | PMID:30537864 |
| GO:0070994 | Detection of oxidative stress | Increases phenotype | PMID:24555655; PMID:33460233; PMID:33460233; PMID:39096083; PMID:36646412; PMID:37172713; PMID:39096083 |
| GO:0071674 | Mononuclear cell migration | Increases phenotype | PMID:8538927 |
| GO:0072378 | Blood coagulation, fibrin clot formation | Increases phenotype | PMID:30537864 |
| GO:0072593 | Reactive oxygen species metabolic process | Affects phenotype | PMID:33497711 |
| GO:0072678 | T cell migration | Increases phenotype | PMID:7763084 |
| GO:0090322 | Regulation of superoxide metabolic process | Increases phenotype | PMID:9863766 |
| GO:0097722 | Sperm motility | Decreases phenotype | PMID:39096083 |
| GO:0098508 | Endothelial to hematopoietic transition | Increases phenotype | PMID:31404653 |
| GO:0140042 | Lipid droplet formation | Increases phenotype | PMID:31071422 |
| GO:1900017 | Positive regulation of cytokine production involved in inflammatory response | Increases phenotype | PMID:25237059 |
| GO:1901670 | Negative regulation of superoxide dismutase activity | Increases phenotype | PMID:26825963; PMID:27837179; PMID:39414706 |
| GO:1901671 | Positive regulation of superoxide dismutase activity | Decreases phenotype | PMID:24970117 |
| GO:1902552 | Negative regulation of catalase activity | Increases phenotype | PMID:26825963; PMID:39414706 |
| GO:1902600 | Proton transmembrane transport | Affects phenotype | PMID:33038468 |
| GO:1903283 | Negative regulation of glutathione peroxidase activity | Increases phenotype | PMID:26825963; PMID:27837179 |
| GO:1903284 | Positive regulation of glutathione peroxidase activity | Affects phenotype | PMID:23650045; PMID:24970117 |
| GO:1903409 | Reactive oxygen species biosynthetic process | Increases phenotype | PMID:22240155; PMID:30359721 |
| GO:1903428 | Positive regulation of reactive oxygen species biosynthetic process | Increases phenotype | PMID:22910795; PMID:24970117; PMID:27837179 |
| GO:1903787 | Negative regulation of glutathione biosynthetic process | Increases phenotype | PMID:39414706 |
| GO:1904480 | Positive regulation of intestinal absorption | Increases phenotype | PMID:31175882 |
| GO:1905898 | Positive regulation of response to endoplasmic reticulum stress | Increases phenotype | PMID:32879258 |
| GO:1990051 | Activation of protein kinase c activity | Increases phenotype | PMID:9405450 |
| GO:2000379 | Positive regulation of reactive oxygen species metabolic process | Increases phenotype | PMID:18409822; PMID:23202902; PMID:9022032 |
| GO:2000516 | Positive regulation of cd4-positive, alpha-beta t cell activation | Increases phenotype | PMID:25237059 |
| GO:2000573 | Positive regulation of dna biosynthetic process | Increases phenotype | PMID:10861847 |
| GO:2001151 | Regulation of renal water transport | Affects phenotype | PMID:15462210 |
We have built a comprehensive resource which compiles potential endocrine disrupting chemicals (EDCs) based on the observed adverse effects or endocrine-mediated endpoints in published experiments on humans or rodents to support basic research. We are not responsible for any errors or omissions in the published research articles or supporting literature on potential EDCs compiled in this resource. Users are advised to exercise their own judgement on the weight of evidence for potential EDCs compiled in this resource. Importantly, our sole goal to build this resource on potential EDCs is to enable future basic research towards better understanding of the systems-level perturbations upon chemical exposure rather than influencing regulatory advice on chemical use.